Strategies for developing biomarkers of heart failure.

Abstract

BACKGROUND Heart failure (HF) is a devastating disease with increasing prevalence in elderly populations. One-half of all patients die within 5 years of diagnosis. The annual cost of treating patients with HF in the US is more than $20 billion, which is estimated to be greater than that of myocardial infarction and all cancers combined. Given the complex… (More)

Topics

6 Figures and Tables

Slides referencing similar topics